These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7909610)

  • 1. Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists.
    Page DM; Alexander J; Snoke K; Appella E; Sette A; Hedrick SM; Grey HM
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):4057-61. PubMed ID: 7909610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide antagonists that promote positive selection are inefficient at T cell activation and thymocyte deletion.
    Barnden MJ; Heath WR; Rodda S; Carbone FR
    Eur J Immunol; 1994 Oct; 24(10):2452-6. PubMed ID: 7925574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific and nonspecific deletion of immature cortical thymocytes caused by antigen injection.
    Martin S; Bevan MJ
    Eur J Immunol; 1997 Oct; 27(10):2726-36. PubMed ID: 9368633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and peptide requirements for in vitro clonal deletion of immature thymocytes.
    Iwabuchi K; Nakayama K; McCoy RL; Wang F; Nishimura T; Habu S; Murphy KM; Loh DY
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9000-4. PubMed ID: 1409596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two signals are required for negative selection of CD4+CD8+ thymocytes.
    Page DM; Kane LP; Allison JP; Hedrick SM
    J Immunol; 1993 Aug; 151(4):1868-80. PubMed ID: 7688388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of thymocyte positive selection does not convey immediate resistance to negative selection.
    Hare KJ; Pongracz J; Jenkinson EJ; Anderson G
    Immunology; 2002 Feb; 105(2):163-70. PubMed ID: 11872091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene.
    Strasser A; Harris AW; von Boehmer H; Cory S
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1376-80. PubMed ID: 8108419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturally occurring low affinity peptide/MHC class I ligands can mediate negative selection and T cell activation.
    Motyka B; Teh HS
    J Immunol; 1998 Jan; 160(1):77-86. PubMed ID: 9551958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting edge: negative selection of immature thymocytes by a few peptide-MHC complexes: differential sensitivity of immature and mature T cells.
    Peterson DA; DiPaolo RJ; Kanagawa O; Unanue ER
    J Immunol; 1999 Mar; 162(6):3117-20. PubMed ID: 10092759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T-cell receptor transgenic mice.
    Mamalaki C; Norton T; Tanaka Y; Townsend AR; Chandler P; Simpson E; Kioussis D
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11342-6. PubMed ID: 1360667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ig-specific T cell receptor-transgenic T cells are not deleted in the thymus and are functional in vivo.
    Granucci F; Rescigno M; Marconi G; Foti M; Ricciardi-Castagnoli P
    J Exp Med; 1996 Jan; 183(1):203-13. PubMed ID: 8551224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The balance between deletion and activation of CD4+8+ thymocytes is controlled by T cell receptor-antigen interactions and is affected by cyclosporin A.
    Curnow SJ; Schmitt-Verhulst AM
    Eur J Immunol; 1994 Oct; 24(10):2401-9. PubMed ID: 7925567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand.
    Müller KP; Mariani SM; Matiba B; Kyewski B; Krammer PH
    Eur J Immunol; 1995 Oct; 25(10):2996-9. PubMed ID: 7589104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental regulation of thymocyte susceptibility to deletion by "self"-peptide.
    Spain LM; Berg LJ
    J Exp Med; 1992 Jul; 176(1):213-23. PubMed ID: 1319457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility and resistance to antigen-induced apoptosis in the thymus of transgenic mice.
    Tarazona R; Williams O; Moskophidis D; Smyth LA; Tanaka Y; Murdjeva M; Wack A; Mamalaki C; Kioussis D
    J Immunol; 1998 Jun; 160(11):5397-403. PubMed ID: 9605140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-stimulated signaling events in immature CD4+CD8+ thymocytes expressing competent T-cell receptor complexes.
    Nakayama T; Samelson LE; Nakayama Y; Munitz TI; Sheard M; June CH; Singer A
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):9949-53. PubMed ID: 1719558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice.
    Zhou T; Bluethmann H; Eldridge J; Brockhaus M; Berry K; Mountz JD
    J Immunol; 1991 Jul; 147(2):466-74. PubMed ID: 1830064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced T cell maturation and altered lineage commitment in T cell receptor/CD4-transgenic mice.
    Lieberman SA; Spain LM; Wang L; Berg LJ
    Cell Immunol; 1995 Apr; 162(1):56-67. PubMed ID: 7704911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peptide antigen antagonist prevents the differentiation of T cell receptor transgenic thymocytes.
    Spain LM; Jorgensen JL; Davis MM; Berg LJ
    J Immunol; 1994 Feb; 152(4):1709-17. PubMed ID: 8120380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deviations in thymocyte development induced by divalent and monovalent ligation of the alpha/beta T cell receptor and by its cross-linking to CD8.
    Yachelini P; Falk I; Eichmann K
    J Immunol; 1990 Sep; 145(5):1382-9. PubMed ID: 1974566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.